- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 30th, 2007
Another goal of the researchers' work is to advance what Liu termed "personalized care." Drugs currently used to treat cancer often kill healthy cells along with cancerous cells. By using PAMP to spot precisely which mutations are causing an individual's cancer, target-specific drugs can be designed to attack only mutated DNA and its protein products. Meanwhile, cells with healthy DNA remain unharmed.
"The project is just starting," Liu said. "A collaborative effort among biological and optical engineers, molecular and computational biologists, nanotechnology experts and physicians is necessary for our research to advance, not to mention the need for a steady stream of funding."
|Related News Press|
Polymeric Nanocarriers Improve Performance of Anticancer Drugs April 30th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
FEI Company: Strong Growth Prospects Remain May 1st, 2015
To Conserve London's 300-Year-Old Masterpiece, Nanotech & Drones April 12th, 2015
2015 Nanonics Image Contest January 29th, 2015
OCSiAl supports NanoART Imagery Contest January 23rd, 2015